Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances.
This report contains market size and forecasts of Subcutaneous Biologics in Global, including the following market information:
Global Subcutaneous Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Subcutaneous Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Syringe Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Biologics include Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb and Eisai Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Subcutaneous Biologics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Biologics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Subcutaneous Biologics Market Segment Percentages, by Type, 2021 (%)
Syringe
Wearable injector
Automatic injector
Implants
Global Subcutaneous Biologics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Subcutaneous Biologics Market Segment Percentages, by Application, 2021 (%)
Hospital pharmacies
Retail pharmacies
Drug stores
Online pharmacies
Global Subcutaneous Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Subcutaneous Biologics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Subcutaneous Biologics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Subcutaneous Biologics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline